The page you are looking for can't be found. Go back or browse our recent articles below.

Go back home

Novartis remibrutinib significantly reduces relapse rates and shows favourable safety profile in phase 3 RMS trials

Phase 3 trials Editor -
Novartis has announced positive topline results from its phase 3 trials of remibrutinib in relapsing multiple sclerosis. Remibrutinib, a highly...

GSK to advance mRNA seasonal flu vaccine candidate to phase 3 following positive phase 2 data

Phase 1-2 trials Editor -
GSK presented positive phase 2 data for its mRNA seasonal influenza (flu) vaccine candidate at the Options XIII Conference...

New phase 3b data on Eli Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults...

Phase 3 trials Editor -
Eli Lilly and Company (NYSE: LLY) has announced 52-week results from Together-PsO and Together-PsA, two novel open-label phase 3b clinical trials...

Acoramidis demonstrates reversal of cardiac structural disease progression and functional decline and significantly increases days alive and free from hospitalisation in ATTR-CM

Phase 3 trials Editor -
BridgeBio Pharma has presented new analyses from the phase 3 study of Attruby (acoramidis) in transthyretin amyloid cardiomyopathy (ATTR-CM),...

AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer

Drug Delivery and Supply Chain Editor -
AstraZeneca has started an exclusive licencing agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), an oral irreversible epidermal growth factor receptor (EGFR)...

Tezspire demonstrates positive phase 3 results in eosinophilic esophagitis across both co-primary and all key secondary endpoints

Phase 3 trials Editor -
Amgen and AstraZeneca have announced positive top-line results from the phase 3 trial of Tezspire (tezepelumab-ekko) in patients living with...
spot_imgspot_img

Late-breaking data for Abbott’s Tactiflex Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases

Phase 3 trials Editor -
Abbott, the global healthcare leader, has announced new late-breaking 12-month data from the FlexPulse Global IDE study that show...

Teva announces positive topline results from phase 2a study in celiac disease for its anti-IL-15 antibody, further validating its pipeline-in-a-product potential

Phase 1-2 trials Editor -
Teva Pharmaceutical has announced positive topline results from an ongoing phase 2a study of TEV ‘408, an investigational anti-interleukin-15...

Raziel Therapeutics and Fosun Pharma announce positive phase 3 results for RZL-012 in submental fat reduction, clearing the path to a China NDA filing

Phase 3 trials Editor -
Raziel Therapeutics has announced positive results from its phase 3 registration trial in China evaluating RZL-012 for the reduction...

Northway Biotech opens (first in Baltics) EUR €61 million cell therapy and personalised medicine CDMO in Vilnius, Lithuania

Editor -
Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding...

AbbVie announces positive topline results from the phase 3 trial showing Etentamig significantly improved response rate and progression-free survival in patients with relapsed/refractory multiple...

Phase 3 trials Editor -
AbbVie has announced positive topline results from a phase 3 study evaluating etentamig, an investigational BCMA x CD3 bispecific T-cell engager,...

InnovHeart announces first US Saturn transseptal TMVR system implant, reaching 15 patients globally

Editor -
InnovHeart, a medical device company developing the Saturn Transseptal Transcatheter Mitral Valve Replacement (TMVR) System, today announces the successful...
Load more